ÂÜÀòÂÒÂ×

The Leadership Team at Disarm Therapeutics drives the strategic vision and direction of the company, overseeing research and development initiatives to create innovative therapeutics for neurological diseases. Comprising experts in biology, molecular discovery, and neuropharmacology, the team collaborates to prioritize projects, secure funding, and foster partnerships that accelerate the development of disease-modifying treatments for axonal degeneration. Their leadership ensures the company's commitment to transforming the lives of patients suffering from central, ocular, and peripheral nervous system disorders.